Next Article in Journal
Hyaluronic Acid-Mediated Phenolic Compound Nanodelivery for Cancer Therapy
Previous Article in Journal
Modified Sulfanilamide Release from Intelligent Poly(N-isopropylacrylamide) Hydrogels
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Toward a New Generation of Bio-Scaffolds for Neural Tissue Engineering: Challenges and Perspectives

by
Francisca Villanueva-Flores
1,*,
Igor Garcia-Atutxa
2,
Arturo Santos
3 and
Juan Armendariz-Borunda
3,4
1
Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Campus Chihuahua, Av. Heroico Colegio Militar 4700, Nombre de Dios, Chihuahua 31300, Chihuahua, Mexico
2
Máster en Bioinformática y Bioestadística, Universitat Oberta de Catalunya, Rambla del Poblenou, 156, 08018 Barcelona, Spain
3
Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Campus Guadalajara, Av. Gral Ramón Corona No 2514, Colonia Nuevo México, Zapopan 45201, Jalisco, Mexico
4
Instituto de Biología Molecular en Medicina y Terapia Génica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Independencia Oriente, Guadalajara 44340, Jalisco, Mexico
*
Author to whom correspondence should be addressed.
Pharmaceutics 2023, 15(6), 1750; https://doi.org/10.3390/pharmaceutics15061750
Submission received: 9 May 2023 / Revised: 4 June 2023 / Accepted: 13 June 2023 / Published: 16 June 2023

Abstract

:
Neural tissue engineering presents a compelling technological breakthrough in restoring brain function, holding immense promise. However, the quest to develop implantable scaffolds for neural culture that fulfill all necessary criteria poses a remarkable challenge for material science. These materials must possess a host of desirable characteristics, including support for cellular survival, proliferation, and neuronal migration and the minimization of inflammatory responses. Moreover, they should facilitate electrochemical cell communication, display mechanical properties akin to the brain, emulate the intricate architecture of the extracellular matrix, and ideally allow the controlled release of substances. This comprehensive review delves into the primary requisites, limitations, and prospective avenues for scaffold design in brain tissue engineering. By offering a panoramic overview, our work aims to serve as an essential resource, guiding the creation of materials endowed with bio-mimetic properties, ultimately revolutionizing the treatment of neurological disorders by developing brain-implantable scaffolds.

Graphical Abstract

1. Introduction

Neurological disorders (ND) are one of the primary human disabilities. ND incidence is expected to increase with the aging population. Conventional pharmacological treatments and surgeries focus on reducing symptoms and palliative care, but not on trying to reverse the illness. The main challenges in treating ND are (a) the absence of structural support to permit a repopulation of the lesion cavity and, (b) the heterogeneity of the particularities of each medical case. For example, patients who have suffered from strokes show vast heterogeneity in both brain and behavioral changes, increasing the difficulty of developing effective neurorehabilitation strategies. In this context, it is necessary to generate medical procedures oriented to personalized medicine [1,2].
Tissue engineering has been proposed as a novel alternative for integrating biological elements with materials used in damaged tissue restoration. Neural tissue engineering is primarily a search for strategies to eliminate inflammation and fibrosis upon implantation of foreign materials able to serve as a scaffold for cellular growth. Scaffolds should imitate the natural extracellular matrix to provide a biomimetic environment for neural development. Moreover, scaffolds must retain their structural integrity and stability during the implantation surgery [3,4].
The ideal scaffold for neural tissue engineering should have the following characteristics: (a) lack of toxicity, (b) allows survival, proliferation, and neuronal migration, (c) favors electrochemical cell communication, (d) shows similar mechanical properties to the brain, and ideally, (e) has the ability to release substances in a controlled manner [5,6].
Many scaffolds have been successfully fabricated using various materials and techniques. One of the most promising materials is based on hydrogels, due to their high-water content that mimics soft tissues. Hydrogels are composed of polyelectrolytes able to slow down the release of oppositely charged small molecules, burst out of the cargo, and change their internal network as a response to external stimuli, i.e., changes involving temperature, pH, ultrasound, glucose, or urea concentrations. This class of hydrogels is known as “smart hydrogels” and has significantly impacted the design of materials for tissue engineering. These materials allow the customization of implants according to the needs of each patient [7,8].
Hyaluronic acid (HA) is an example of a widely studied natural polymer that increases the survival rate of dopaminergic neurons and stem cells. HA has been proposed as a promising material for Parkinson’s disease treatment and other therapies for cell replacement [9,10,11]. Nowadays, many natural and synthetic hydrogels are being tested in preclinical trials for peripheral nerve regeneration, with the capacity to release drugs in a controlled manner, expanding their applications [12]. Only collagen has shown satisfactory results in clinical trials for nerve regeneration, but none for brain implantation [13,14].
Some significant drawbacks of hydrogels are their poor mechanical properties, lack of roughness, and high impedance. These are important parameters for adequate neuronal development. Thus, many strategies have been explored to improve hydrogels’ mechanical properties, such as adding carbon nanotubes (CNT) and graphene. These modifications have also enhanced conductivity, making neuronal electrical stimulation possible [15,16,17,18,19]. Unfortunately, many authors have reported the toxicity of carbon derivatives, which lead to inflammation, fibrosis, lung cancer, fetal malformations, oxidative stress, and DNA damage, among others. Other works have explored the use of conductive polymers, but their safety has not yet been established [20,21,22].

2. The Challenge of Designing Materials for Neuron Tissue Engineering

The Food and Drug Administration (FDA) has only approved nerve conduits for peripheral nerve repair, while translational products addressing more complex neurological issues are minimal. Injuries in the brain often lead to poor prognoses because of its inability to self-repair. Therefore, developing materials for neural tissue engineering is a major challenge, due to the difficult restoration of functional connectivity between various axons, neural circuits, and non-neuronal cells [23].
A promising strategy for neural tissue restoration is the design of scaffolds that provide a suitable environment for mammalian cell growth and, eventually, develop into a platform for the replacement of the damaged tissue. Scaffolds may have different configurations and elements that together act as templates where cells can proliferate or serve as chemical or physical cell stimulators [24]. Overall, all the physicochemical properties of the scaffold determine how cells interact with the material and ultimately determine the success or failure of the implant [25].
The following sections address the main requirements of materials for brain tissue engineering.

3. Main Requirements for Scaffolds for Brain Tissue Engineering

Scaffolds for tissue engineering offer a vast array of possibilities regarding materials and techniques, tailored to the specific needs of the target tissue. Certain key characteristics are crucial for the brain or any other tissue. Biocompatibility and mechanical properties compatible with the target tissue are fundamental for success. In the case of brain scaffolds, additional factors come into play. An optimal topography that promotes neuron attachment, a surface that can be finely tuned, and the ability to immobilize substances within the material core (think antibiotics, anti-inflammatory drugs, growth factors, and neurotrophic factors) are essential. Porosity is also crucial, as it allows for ion exchange and the movement of substances. Moreover, brain scaffolds must minimize microglia activation, ensuring a favorable environment for neuronal growth. Ideally, these scaffolds possess electrical conductivity, which facilitates interneuron communication. To summarize, Figure 1 presents the main parameters to consider when designing scaffolds for brain tissue engineering, serving as a valuable guide in this exciting field.

3.1. Biocompatibility and Biodegradability

The most important and obvious characteristics of all scaffolds for tissue engineering are biocompatibility and safety. At the cellular level, the scaffold should allow cell attachment, migration, and proliferation, to favor cells, and the scaffold gets fused to form a functional bio-scaffold. On the other hand, at the tissular level, the scaffold should not be immunogenic to be accepted by the body, and, importantly, it should not be fibrogenic [26].
Many materials have been demonstrated to be biocompatible in the body but fail when they are implanted in the brain. The reason for brain rejection is the brain’s privileged immune response. Unlike the rest of the body, the brain is protected by the blood–brain barrier, a highly selective barrier that allows the passing of just certain substances (water, oxygen, carbon dioxide, etc.) and avoids others (bacteria, viruses, some drugs, etc.). Moreover, the brain lacks lymphatic vessels and antigen-presenting cells. In the brain, foreign substance recognition occurs with the activation of microglia. Activated microglia has two states: (a) the M1 state (proinflammatory), where peripheral leukocytes are infiltrated into the tissue to combat and eliminate infection or injury, and (b) the M2 state (anti-inflammatory), where anti-inflammatory cytokines facilitate phagocytosis of cellular debris and promote the extracellular matrix restoring and tissue repair [27].
The study of brain immune response against intracranially implanted devices has gained attention. After implantation, microglia are immediately activated. Microglia extend their processes to the implant surface (around 130 µm). Twenty-four hours post-implantation, the implanted device is fully surrounded by activated microglia, forming a thin cell capsule. The cellular capsule may limit the ionic exchange and interferes with neuronal communication. During the first week post-implantation, astrocytes are fully activated, and two or three weeks later, astrocytes form a sheath around microglia. Four weeks after implantation, glial cells form tight junctions with each other that limit ion and neurotransmitter diffusion, which ultimately leads to neuronal death and neurite degeneration (approximately 150 µm in radius) [28,29,30].
Biodegradable implantable devices can reduce potential immunological side effects [31]. Natural hydrogels are the most studied materials for scaffold design that offer mechanical support for neuron growth [32]. A simplified scheme of an implanted hydrogel used as a platform for exogen cell culture and the process for restoring the neuronal connection between exogen and host cells is shown in Figure 2. After a while, it is expected that the brain implant is fully degraded, and a patch of cells establish novel connections restoring the natural function.
The possible toxic effects of the degradation subproducts are often neglected in the literature. Further research should be conducted to study their side effects in vivo in the long-term.

3.2. Mechanical Properties

Scaffolds for tissue engineering should be compatible with the target tissue, both at cellular and tissular levels. At the cellular level, adherent cells apply contractile forces on the material and can sense material hardness. Otherwise, variations in hydrogel stiffness, density, composition, orientation, and viscoelastic characteristics all affect cell activity and phenotypes such as morphology, spreading, genetic regulation, axonal development, and cell differentiation. At the tissular level, the scaffolds’ mechanical properties should be like the anatomic site for implantation to minimize friction and be strong enough to allow surgical manipulation [33,34,35].
Robinson et al. (2019) have recently reported a practical and non-destructive method for acquiring the elastic modulus of fibrin using a modified Hertz model for thin films. This method can be applied to characterize the mechanical properties of engineered neural tissues [36]. The study of the scaffolds’ mechanical properties on the neuronal phenotype may be exploited in the design of bioengineered scaffolds that promote nerve regeneration upon injury [37,38].
The brain is the softest organ in the body. Designing a material imitating the mechanical properties of the brain and, at the same time, possessing enough hardness to allow cell attachment, is an additional challenge. A comparison between brain stiffness and other tissues and substrates for brain tissue engineering is shown in Figure 3. As can be seen, the brain is barely 0.1–0.3 kPa in stiffness, which is the lowest value in comparison to lung and breast tissue, endothelium, and soft muscle (Figure 3a) [39]. Some of the most-studied polymers for tissue engineering, because of their similar mechanical properties to soft tissues, are polyacrylamide (PAAm), poly(ethylene glycol) (PEG), polydimethylsiloxane (PDMS), polystyrene (PS), poly(lactic-co-glycolic acid) (PLGA), and poly-ε-caprolactone (PCL) (Figure 3b). These materials have been applied as substrates for the culture of various cells such as neurons, adult stem cells, glial cells, rat neural stem cells, and human mesenchymal stem cells, among others [40,41].
Neurons migrate, proliferate, extend their neurites, and develop actin filaments, both soft (0.1 kPa) and hard (GPa) substrates. In contrast, astrocytes proliferate on hard substrates preferentially. It has been observed that co-cultures of neurons and astrocytes growing on soft substrates favor an increased growth of neurons instead of astrocytes. A differential growth may be an advantage for a brain implant because neuronal regeneration is privileged. Otherwise, the development of the glial scar can be decreased [42]. Further research should be conducted to explore the preferential growth of certain cell lineages in co-cultures using scaffolds of various stiffnesses.

3.3. Topography

As was previously discussed, neurons are very sensitive to substrate topography. Nanostructured surfaces that imitate extracellular matrix architecture support cell spreading, proliferation, attachment, neurite extension and branching, migration, and the transmission of electrical signals. Moreover, topography influences neural stem cell differentiation [43,44].
Neurons utilize filopodia as their cellular protrusion organelles and depend on specific integrin-mediated adhesions to the local extracellular matrix for guidance in their pathfinding [45]. Recently, a universal mechanism has been proposed for cell alignment in response to substrate topography. This hypothesis indicates that cells may interact with a scaffold through specific surface ligands called focal adhesions. Focal adhesions and actin stress fibers determine cell attachment and spread, through anisotropic force generation, cellular elongation, and alignment. In other words, the control of contact guidance is influenced by a balance of cell-substratum and cell–cell interactions, modulated by cell phenotype-specific cytoskeletal arrangements [46].
The current design of scaffolds for brain tissue engineering is focused on mimicking the natural extracellular matrix topography. Various techniques have been used to frame high-resolution reliefs, to study the cell response to nano topography [47]. Nanofibers and aligned carbon nanotubes enhance biocompatibility, neurite extension, direction, and the branching of neurites, and the alignment of glial cells. In addition, fiber diameter also influences cell differentiation, as has been observed in neural stem cell culture on aligned fibers of poly(lactic) acid (PLLA) of 250 nm in diameter. In contrast, neural stem cells remain undifferentiated when grown on aligned PLLA fibers of different diameters. Cells can grow independently from the fiber’s diameter, but surprisingly, fibers of 250 nm in diameter trigger cell differentiation. Cells have been observed to suffer no changes when grown on aligned PLLA nanofibers of 1.25 µm in diameter [48,49,50,51,52,53,54,55].
Neurons have been cultured on isotropic surfaces (materials with a homogeneous distribution of particles on a solid substrate). Surfaces were built with pillars and holes at the nanometric and micrometric scale in aligned patterns. Pillars of 2 µm were separated by holes of 1.5 µm in diameter. Neuron growth alignment was lost when pillars were separated by more than 3 µm or placed on plane substrates. The study of contact guidance is key to many potential biomedical applications for future brain implants, with improved neurite outgrowth [56,57,58,59].
In a different study, [60] reported that mouse neuroblastoma cells (Neuro2A), grown on a nanostructured silicon substrate, can conduct information 3 to 4 times more efficiently compared to random networks on flat surfaces after 11 days after seeding [36,60]. Further research should be conducted to understand, at the molecular level, the influence of topography in neuronal development, to fabricate better scaffolds for brain tissue engineering. It has been proposed that energetic interactions at the cell–nanomaterial interface favor the synergy between the substrate topography and the cell biochemical signals. Together, they allow the orientation of dendrites and even accelerate neuronal development by up to 1.54 times [47,61,62,63].
Current approaches to designing materials for brain tissue engineering should consider the topography of scaffolds to provide a nano-structured or micro-structured environment to provide growth guidance, control cell differentiation, and favor the integration of the regenerated tissue. Nanostructures direct the extension of axons and induce unique branching morphologies [64]. It was recently observed that the implantation of cultured neuroglia cells into an aligned scaffold of PCL fibers improves sciatic nerve regeneration in rats [65]. The underlined mechanisms of how neurons respond to different nano-topographies and micro-topographies remain unknown. Further research should be conducted to explore novel neural guides and their effect on physiology to create better scaffolds for brain tissue engineering.
An interesting example of the application of the influence of 3D micro morphologies on neural culture is a technology called NeuroGrid®, (Silicon Group, Stanford, CA, USA) [66]. NeuroGrid® is a scaffold with defined porous and non-porous regions in its structure that can be used to transfer and manipulate organoids for analytical purposes. NeuroGrid® geometries were inspired by the size of neuronal fiber bundles, (approximately 500 µm) to guide the connectivity between 3D neuronal cell clusters, resulting in a useful tool to create more uniform spheroids with defined diameters. Moreover, NeuroGrid® was able to connect a multi-electrode array (MEA) system to record neuronal activity. This tool can potentially revolutionize how we approach new methodologies to understand neural connectivity to neural tissue engineering [66].

3.4. Porosity

Interconnected porous hydrogels exhibit favorable cellular responses compared with traditional non-porous materials [67]. Pore size determines the diffusion rate of nutrients and waste removal. A substrate with an appropriate pore size, facilitates cell seeding, cell penetration, oxygen diffusion, and distribution in the scaffolds. In addition, pore size strongly influences cell adhesion, cell-to-cell interaction, and spreading. Neurons can sense the scaffold surface. Focal adhesions regulate signaling complexes and integrin function and initiate a signaling cascade that stimulates cell proliferation and differentiation [68,69].
Electrospinning has emerged as a promising method for designing materials with controlled porosity. Electrospinning is a versatile, efficient, cheap, and reproducible technique to produce extremely interconnected thin fibers and highly porous microstructures by applying an electrostatic force to a given solution. Many scientific articles report electrospinning as a tool for designing innovative neural scaffolds. Along with these lines, using electrospinning, Moztarzadeh and Sadeghi (2016), generated hyaluronic acid and polycaprolactone nanofibers of various porosities. SH-SY5Y, human neuroblastoma cells, were cultured on the scaffold. The authors found that there is an ideal porosity that facilitates neuronal growth. These results highlight porosity’s importance in eliciting an adequate neuronal growth environment. Moreover, it has been observed that porous scaffolds with anisotropic structures can also be produced to guide cellular proliferation [70]. According to a number of authors, the ideal pore size for neuron culture is around 95–150 µm [67,71,72,73].
Although pore volume can be easily determined using the BET method, based on N2 adsorption isotherms using a surface area analyzer, BET analysis requires samples to be completely dried. The drying process alters the internal structure and does not necessarily reveal the real porosity for in vivo applications [74]. Atomic force microscopy (AFM) is one of the microscopic techniques with the highest resolution, that can be applied to characterizing morphological surfaces. The method oscillates ever near the sample surface to form a capillary neck between the tip and the sample, leading to hysteresis in the force-distance curve. Unlike BET, wet samples can be analyzed in AFM more accurately to real-life conditions [75].
Studies on the influence of scaffolds’ pore size are scarce in the literature. Further research is needed to understand the fluid mechanics inside the network to optimize the pore size, guarantee an adequate flux of nutrients and waste removal, and optimize cell attachment.

3.5. Immobilization of Active Substances

Immobilizing active substances has resulted in a good strategy to improve host tissue integration with the brain implant, enhance biocompatibility, and provide additional functionality for the scaffold [76,77,78].
Hydrogels usually present low interfacial tension. Thus, they often require the immobilization of substances to support cell attachment. For example, collagen or HA do not require additional functionalization because they naturally possess peptide ligands of type RGD that mimics key biochemical and mechanical features of the brain’s matrix [79]. Synthetic scaffolds are typically covered with poly-L-lysin, fibronectin, gelatin, laminin, collagen, and peptides such as RGD, IKVAV, GRGDS, mi- GDPGYIGSR, and mi-GQASSIKVA, among others [80,81,82,83,84].
The immobilization of growth factors is a successful strategy to enhance scaffold biocompatibility. Three-dimensional cultures carried on scaffolds, with sustained growth factor release, are considered more likely to succeed than conventional methods [85]. A neuronal growth factor is any substance that influences the growth of neurons, and they are also involved in tissue repair and vascularization in such a way that they are very interesting substances to help the integration of the implant with the host tissue [86,87]. Some examples of immobilized growth factors in scaffolds for neural tissue engineering and their advantages are listed in Table 1.
The controlled release of bioactive substances in brain implantable devices primarily relies on simple diffusion, which is regulated by adjusting the cross-linking degree of biopolymer-based scaffolds. However, there is an intriguing opportunity to explore the use of conductive materials and harness the natural electrical activity in the brain. Additionally, investigating the application of “molecular switches” holds promise for modulating the release rate of bioactive agents. It is important to note that, as of what is currently known, these strategies lack in vivo evidence of brain-implanted hydrogels with immobilized bioactives, and further research is needed to evaluate their potential long-term toxicity.

3.6. Conductivity

Conductive materials are proposed as promising scaffolds for electrical stimulation. The effects of electrical stimulation have been widely studied. Electrical stimulation enhances axonal regeneration and catecholamine release [96,97,98]. Electrical stimulation is an FDA-approved procedure for Parkinson’s disease treatment, obsessive compulsive disorder, and depression [99,100,101,102]. Moreover, conductive polymers offer new approaches to the functional recovery of the post-stroke brain [103,104].
Technological advances in electrical recording and electrical stimulation have contributed to the understanding of neural networks and enabled individual neuron activation [105]. Unlike in past decades, up-to-date technology can perform electrical stimulation with high spatial accuracy [106].
Carbon-derived materials and conductive polymers have gained significant attention in the development of scaffolds for neuron electrical stimulation. As a result of electrical stimulation, neurons differentiate and develop longer neurites [107,108,109,110]. Carbon nanotubes (CNT) and graphene have been applied to develop conductive scaffolds for neural tissue engineering. Neurons were found to be able to form tight contacts between the proximal and distal compartments and showed increased synaptic frequencies when grown on carbon-derived substrates [111,112,113]. On the other hand, neurons have also shown increased cytotoxicity due to the oxidative stress caused by carbon nanotubes and graphene [114,115,116]. In murine models, carbon-derived materials have also triggered inflammation, fibrosis, lung cancer, fetal malformations, and DNA damage. Cytotoxicity has limited carbon-derivatives in clinical applications [117,118].
Many conductive polymers have been studied to develop materials for neuronal scaffolds and potential electrical stimulators. Conductive polymers allow the direct transfer of electrical, electrochemical, and electromechanical stimuli to cells. Conductive polymers possess π-conjugated electrons in their unsaturated bonds for them to be able to move, so that the π-electrons can open electrical paths. Some examples of conductive polymers applied in neuronal scaffolds are polypyrrole (Ppy) [119,120], polyaniline (PANi) [121,122], poly(3,4-ethylene dioxythiophene) (PEDOT) [123,124], and polythiophene [125,126].
Ppy is a biocompatible polymer that enables neuronal reconnection. Ppy provides a neuroprotective environment, can release growth factors, and enables electrical stimulation, which favors dendrite growth and neuronal stem cell differentiation [127]. However, Ppy is very difficult to solubilize once synthesized, in addition to being mechanically rigid and brittle, which makes it impractical for surgical procedures [54].
PANi, is another biocompatible polymer with neuronal cultures. It is a low-cost and chemically stable material and has the potential to demonstrate electroactive behavior when doped with acids, whereas, in the presence of a base, its electroactive characteristics deteriorate. However, it has been observed that using PANi induces chronic inflammation in rats [128]. The toxic effects of implanted PANi-based materials should be studied in more detail.
PEDOT has been applied in the construction of neuronal culture scaffolds, releasing growth factors, and electrical stimulation. Its use in neuronal cultures has led to increases in the length of neurite outgrowth. Experimental evidence suggests that PEDOT shows a low immunogenic response when implanted in a rat cortical cortex. However, neurons have shown a loss of F-actin stress fibers when cultured on PEDOT. Moreover, neurons have been seen to begin to die of apoptosis after one-week post-implantation [129,130]
Many challenges remain to be overcome before using conductive polymers as brain implants [121,131]. Vigorous basic and clinical research must be carried out to develop conductive polymers for electrical stimulation of neurons, with no adverse cytotoxic effects, to generate safe devices for medical applications.

4. Materials and Techniques Commonly Used for the Fabrication of Bioscaffolds for Neural Tissue Engineering

Here, we provide a comprehensive summary of the most frequently utilized polymers for scaffold fabrication in brain tissue engineering, facilitating the selection of appropriate materials based on desired scaffold properties (see Table A1, Appendix A). Table A2 outlines the current techniques employed for scaffold fabrication in brain tissue engineering, enabling researchers and practitioners to identify suitable approaches for scaffold production, considering the advantages and disadvantages of each technique, and examples of the materials with which techniques have been applied (see Table A2, Appendix B). The usability of these tables aids in streamlining the decision-making process for scaffold design, ultimately in enhancing the efficiency and effectiveness of brain tissue engineering research and development.

5. Future Perspectives

The design of scaffolds for brain tissue production is not trivial. Materials should be scalable with regard to morphology and structure, i.e., pore size, mechanical properties, nano-topography, biochemical cues, electrical properties, etc. The way that cells respond to artificial substrates with determined physicochemical properties is far from being fully understood [132,133].
Incorporating nanotechnology can enable the tailoring of molecular interactions between neurons, glial cells, astrocytes, and scaffolds [134]. Future research should be conducted to understand those interactions in 3D cultures and organoids, due to the better accuracy in replicating the microenvironment of neural tissues instead of traditional 2D cultures that often limit real-life interactions in vivo [135].
Among all fabrication techniques for scaffolds, 3D bioprinting is an emergent and powerful bio-fabrication strategy. Unlike previous techniques, 3D bioprinting offers the possibility of positioning biologics, including living cells and extracellular matrix components, in combination with inert materials. Three-dimensional bioprinting aims to revolutionize the future design of scaffolds for the next generation of brain tissue implant engineering [136,137].

6. Conclusions

The urgent need to address global health concerns and replace damaged tissues has propelled the convergence of innovative approaches, designs, and technologies toward restoring functional tissues. In the realm of brain tissue engineering, we have identified two critical challenges demanding our attention and expertise: Firstly, unraveling the intricate cell interactions with nano-topographies, which hold the key to determining cell fate, phenotype, and behavior. Secondly, obtaining a material that meets the stringent requirements of biocompatibility, safety, biodegradability, porosity, topography, controlled substance release, and conductivity while maintaining precise quality control and reproducibility.
In this dynamic context, the construction of scaffolds emerges as a transformative avenue, offering an array of captivating advantages. By embracing this approach, we open doors to developing scalable, reproducible, and inherently safe medical devices that faithfully replicate the natural extracellular matrix environment. With every step forward in scaffold engineering, we propel the boundaries of possibility, inching closer to a future where neurologically impaired individuals can experience restored brain function and renewed hope.

Author Contributions

F.V.-F.: conceptualization, original draft preparation, writing—reviewing and editing, funding acquisition; I.G.-A.: conceptualization, writing—reviewing and editing; A.S.: writing—reviewing and editing, funding acquisition; J.A.-B.: writing—reviewing and editing, funding acquisition. All authors have read and agreed to the published version of the manuscript.

Funding

This work was performed thanks to the financial support of Tecnologico de Monterrey. We would like to thank the Grupo de Innovación diagnóstica y terapéutica en enfermedades crónico-degenerativas of the Escuela de Medicina y Ciencias de la Salud of Tecnologico de Monterrey and Ana Apodaca for her technical support.

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Appendix A

Table A1. Main polymers used for the design of scaffolds in brain tissue engineering.
Table A1. Main polymers used for the design of scaffolds in brain tissue engineering.
MaterialOriginCharacteristicsApplicationsReferences
AlginateNaturalHydrogel-based biodegradable scaffold.Axonal regeneration.[138]
CelluloseNaturalHydrogelTissue repair, stem cell therapy, anti-inflammatory drug delivery.[139]
ChitosanNaturalHydrogel-based biodegradable scaffold.Restoration of cell function, axonal regeneration, drugs, and neurotrophic factor release.[140,141,142]
CollagenNaturalHydrogel-based biodegradable scaffold.Cell survival and proliferation, tissue repair, restoration of cell function, growth factors release, axonal regeneration, and stem cell therapy. To date, this is the only material in clinical trials used for neural tissue engineering. [143,144]
Nanopeptide hydrogelNaturalHydrogel-based biodegradable scaffold.Cell survival and proliferation, tissue repair, restoration of cell function, angiogenesis.[145]
GelatinNaturalHydrogel-based biodegradable scaffold.Cell survival, proliferation, blood–brain barrier restoration, tissue repair, anti-inflammatory properties, and stem cell therapy.[146,147,148]
HANaturalHydrogelCell survival; axonal regeneration, growth factor release; stem cell therapy; promotion of glial, neuronal, or immature/progenitor states; vascularization.[88,149,150]
XyloglucanNaturalHydrogelAxonal regeneration, tissue repair, stem cell survival.[151]
PVASyntheticHydrogel-based scaffold.Cell survival and proliferation, controlled drug release.[152]
PCLSyntheticHydrogel-based biodegradable scaffold.Axonal regeneration, cell survival, restoration of cell function, neurotrophic factors release, stem cell therapy.[132,153]
PEGSyntheticHydrogel-based biodegradable scaffold.Axonal regeneration, reduced microglia and astrocyte response; and neurotrophic factor release.[154,155]
PHEMASyntheticHydrogel-based scaffold.Axonal regeneration, cell survival, growth factor release.[156]
PHMASyntheticHydrogelAxonal regeneration, anti-inflammatory properties.[157]
PLGASyntheticHydrogel-based biodegradable scaffold.Axonal regeneration, vascularization, tissue repair. [158]
PolyurethanSyntheticHydrogel-based biodegradable scaffold.Axonal regeneration, cell survival, cell function restoration, and stem cell therapy. [107,159,160]
PuraMatrix®SyntheticHydrogel-based biodegradable scaffold.Stem cell therapy. [161]
PpySyntheticConductive scaffold Axonal regeneration, cell proliferation, drug release, electrical stimulation. [162,163]
PANiSyntheticConductive scaffold Axonal regeneration, cell proliferation, drug release, electrical stimulation.[164]
PEDOTSyntheticConductive scaffold Axonal regeneration, cell proliferation, drug release, electrical stimulation, and recording.[129,165]
HA: hyaluronic acid, PCL: Poly-ε-caprolactone, PVA: Poly(vinyl alcohol co-vinyl acetate), PANi: Polyaniline, PEDOT: Poly (3,4-ethylenedioxythiophene), PEG: Poly(ethylene glycol), PHEMA: Poly(2-hydroxyethyl methacrylate), PHMA: Poly(2-hydroxypropyl methacrylate), PLGA: Poly(lactic-co-glycolic acid), Ppy: Polypyrrole.

Appendix B

Table A2. Pros and cons of the main fabrication methods used in the design of scaffolds in brain tissue engineering.
Table A2. Pros and cons of the main fabrication methods used in the design of scaffolds in brain tissue engineering.
Fabrication MethodPrincipleProsConsExamples of MaterialsReferences
ElectrospinningElectrospinning uses electricity and fluid dynamics to create fibers. It starts by electrifying a liquid droplet, which then forms a jet. This jet is then stretched and elongated to produce one or more fibers.*Wide material choice.
*Nanofibrous architecture that offers benefits for cells.
*Simplicity.
*Poor scalability.
*Low reproducibility.
*Difficulties in creating 3D scaffolds with well-defined pore architecture.
*No shapes other than cylinders and sheets are possible.
PLGA, PCL, PEO, PVA, collagen, gelatin, chitosan, silk protein, fibrinogen.[166,167]
Solvent castingSolvent casting utilizes the evaporation of certain solvents to create scaffolds in a mold.*Simple procedure.
*Pore size can be controlled using appropriate molds.
*Easy incorporation of drugs into the scaffold.
*Use of highly toxic solvents.
*Poor pore interconnectivity.
PCL, PLA.[168]
Soft lithographySoft lithography is a collection of techniques that involve fabricating or replicating structures using elastomeric stamps, molds, and conformable photomasks. *Low cost.
*High biocompatibility.
*High resolution (5 to 100 nm).
*The resolution can be reduced by the diffusion of ink.GPS, PMMA, soft-gel materials.[169,170]
ElectrosprayElectrospray uses a conductive solvent to create micro and nanoparticles from a polymer solution. Unlike electrospinning, the size and shape of the particles produced can be controlled by adjusting factors such as concentration, solvent choice, and viscosity.*Wide material choice.
*Formation of homogeneous nanoparticles.
*Simplicity.
*Nanoparticles with high loading capacity.
*Poor scalability.
*No shapes other than nano and microspheres.
Chitosan.[171]
Porogen leachingPorogen leaching entails casting a solution of polymer and porogen into a mold, drying the mixture, evaporating the solvent, and then leaching the embedded porogen with water to create pores.*Control over porosity and pore geometry.
*Low-cost.
*Inadequate pore size and interconnectivity.PLA, alginate, gelatin.[172]
Self-assemblyA natural arrangement of molecules, where disordered entities organize into ordered structures due to specific interactions (van der Waals forces, hydrophobic, electrostatic, hydrogen bonding, π–π aromatic stacking, metal coordination, etc.) among the components.*Control over porosity and fiber diameter.
*Regular structures are obtained.
*Simple and versatile strategy.
*Mimics natural structures.
*Minimal control over the shape.
*Limited use of materials.
Silk, liposomes, VLP, DNA.[173,174]
BioprintingBioprinting is an additive manufacturing technique involving layer-by-layer printing of living cells using bioinks. This process aims to create structures that mimic the behavior and structures found in natural tissues.*Offers flexibility, customization, scalability, reliability, durability, and relatively high speed.
*Enables the design of both 2D and 3D structures.
*Expensive
*Limited cell viability.*Poor reproducibility and scalability.
*It is challenging to recreate the intricate microarchitecture and vascular networks.
PCL, PLA, PLGA, PEO/PBT, pluronic, GelMA, HA, PVA.[175]
Microcontact printingMicrocontact printing involves creating a stamp or mold with the desired pattern or features on its surface. The stamp is then inked or coated with a material, such as an ink or self-assembled monolayer, which can adhere to the substrate.*Enables the patterning of proteins of interest on substrates.
*Low-cost.
*Poor reproducibility and scalability.
*It is not possible to print different molecules with one stamp.
*It is difficult to control the amount of protein transferred.
PVA, polyacrylamide, GelMA, graphene.[176]
Gas foamingGas foaming utilizes gas, such as carbon dioxide, as a porogen instead of a solvent. *Generates highly porous scaffolds.
*Low-cost.
*Eliminaes the need for harsh chemical solvents.
*Limited mechanical properties.
*Inadequate pore interconnectivity.
*Poor control of pore size.
PLGA, PEG.[177,178]
PLGA: Poly(lactic-co-glycolic acid), PCL: Poly-εcaprolactone PEO: Poly(ethylene oxide), PVA: Poly(vinyl alcohol), PLA: Poly(D,L-lactide), GPS: Graphene oxide-based patterned substrate, PMMA: Poly(methyl methacrylate), VLP: Virus-like particles, PEO/PBT: Poly(ethylene oxide terephthalate-co-butylene terephthalate, HA: Hyaluronic acid, GelMA: Gelatin methacrylate, PEG: Poly(ethylene glycol).

References

  1. Pina, S.; Ribeiro, V.P.; Marques, C.F.; Maia, F.R.; Silva, T.H.; Reis, R.L.; Oliveira, J.M. Scaffolding Strategies for Tissue Engineering and Regenerative Medicine Applications. Materials 2019, 12, 1824. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Gilmour, G.S.; Nielsen, G.; Teodoro, T.; Yogarajah, M.; Coebergh, J.A.; Dilley, M.D.; Martino, D.; Edwards, M.J. Management of functional neurological disorder. J. Neurol. 2020, 267, 2164–2172. [Google Scholar] [CrossRef] [Green Version]
  3. Dehqan Niri, A.; Karimi Zarchi, A.A.; Ghadiri Harati, P.; Salimi, A.; Mujokoro, B. Tissue engineering scaffolds in the treatment of brain disorders in geriatric patients. Artif. Organs. 2019, 43, 947–960. [Google Scholar] [CrossRef] [PubMed]
  4. Martinez, B.; Peplow, P.V. Biomaterial and tissue-engineering strategies for the treatment of brain neurodegeneration. Neural Regen. Res. 2022, 17, 2108–2116. [Google Scholar] [CrossRef] [PubMed]
  5. Zhang, H.; Zhou, L.; Zhang, W. Control of scaffold degradation in tissue engineering: A review. Tissue Eng. Part B Rev. 2014, 20, 492–502. [Google Scholar] [CrossRef]
  6. Shafiee, A.; Atala, A. Tissue Engineering: Toward a New Era of Medicine. Annu. Rev. Med. 2017, 68, 29–40. [Google Scholar] [CrossRef]
  7. Echeverria Molina, M.I.; Malollari, K.G.; Komvopoulos, K. Design Challenges in Polymeric Scaffolds for Tissue Engineering. Front. Bioeng. Biotechnol. 2021, 9, 617141. [Google Scholar] [CrossRef]
  8. Peressotti, S.; Koehl, G.E.; Goding, J.A.; Green, R.A. Self-Assembling Hydrogel Structures for Neural Tissue Repair. ACS Biomater. Sci. Eng. 2021, 7, 4136–4163. [Google Scholar] [CrossRef]
  9. Ballios, B.G.; Cooke, M.J.; Donaldson, L.; Coles, B.L.; Morshead, C.M.; van der Kooy, D.; Shoichet, M.S. A Hyaluronan-Based Injectable Hydrogel Improves the Survival and Integration of Stem Cell Progeny following Transplantation. Stem Cell Rep. 2015, 4, 1031–1045. [Google Scholar] [CrossRef] [Green Version]
  10. Adil, M.M.; Vazin, T.; Ananthanarayanan, B.; Rodrigues, G.M.C.; Rao, A.T.; Kulkarni, R.U.; Miller, E.W.; Kumar, S.; Schaffer, D.V. Engineered hydrogels increase the post-transplantation survival of encapsulated hESC-derived midbrain dopaminergic neurons. Biomaterials 2017, 136, 1–11. [Google Scholar] [CrossRef]
  11. Marcus, M.; Baranes, K.; Park, M.; Choi, I.S.; Kang, K.; Shefi, O. Interactions of Neurons with Physical Environments. Adv. Healthc. Mater. 2017, 6, 1700267. [Google Scholar] [CrossRef] [Green Version]
  12. Burdick, J.A.; Mauck, R.L.; Gerecht, S. To Serve and Protect: Hydrogels to Improve Stem Cell-Based Therapies. Cell Stem Cell. 2016, 18, 13–15. [Google Scholar] [CrossRef] [Green Version]
  13. Yang, J.M.; Olanrele, O.S.; Zhang, X.; Hsu, C.C. Fabrication of Hydrogel Materials for Biomedical Applications. Adv. Exp. Med. Biol. 2018, 1077, 197–224. [Google Scholar] [CrossRef]
  14. Mirzaei, S.; Kulkarni, K.; Zhou, K.; Crack, P.J.; Aguilar, M.I.; Finkelstein, D.I.; Forsythe, J.S. Biomaterial Strategies for Restorative Therapies in Parkinson’s Disease. ACS Chem. Neurosci. 2021, 12, 4224–4235. [Google Scholar] [CrossRef]
  15. Guo, W.; Qiu, J.; Liu, J.; Liu, H. Graphene microfiber as a scaffold for regulation of neural stem cells differentiation. Sci. Rep. 2017, 7, 5678. [Google Scholar] [CrossRef]
  16. Vashist, A.; Kaushik, A.; Vashist, A.; Sagar, V.; Ghosal, A.; Gupta, Y.K.; Ahmad, S.; Nair, M. Advances in Carbon Nanotubes-Hydrogel Hybrids in Nanomedicine for Therapeutics. Adv. Healthc. Mater. 2018, 7, e1701213. [Google Scholar] [CrossRef]
  17. Sang, S.; Cheng, R.; Cao, Y.; Yan, Y.; Shen, Z.; Zhao, Y.; Han, Y. Biocompatible chitosan/polyethylene glycol/multi-walled carbon nanotube composite scaffolds for neural tissue engineering. J. Zhejiang Univ. Sci. B 2022, 23, 58–73. [Google Scholar] [CrossRef]
  18. Wang, Z.; Wang, J.; Shi, X.; Zhu, Z.; Chen, P.; Peng, H. Electronic Neurons for a New Learning Paradigm. Adv. Healthc. Mater. 2023, 28, e2203247. [Google Scholar] [CrossRef]
  19. Al-Hadeethi, Y.; Nagarajan, A.; Hanuman, S.; Mohammed, H.; Vetekar, A.M.; Thakur, G.; Dinh, L.N.M.; Yao, Y.; Mkawi, E.M.; Hussein, M.A.; et al. Schwann cell-matrix coated PCL-MWCNT multifunctional nanofibrous scaffolds for neural regeneration. RSC Adv. 2023, 13, 1392–1401. [Google Scholar] [CrossRef]
  20. Cheng, Y.; Chen, Z.; Yang, S.; Liu, T.; Yin, L.; Pu, Y.; Liang, G. Nanomaterials-induced toxicity on cardiac myocytes and tissues, and emerging toxicity assessment techniques. Sci. Total Environ. 2021, 800, 149584. [Google Scholar] [CrossRef]
  21. Witkowska, M.; Florek, E.; Mrówczyński, R. Assessment of Pristine Carbon Nanotubes Toxicity in Rodent Models. Int. J. Mol. Sci. 2022, 23, 15343. [Google Scholar] [CrossRef] [PubMed]
  22. Lazăr, A.I.; Aghasoleimani, K.; Semertsidou, A.; Vyas, J.; Roșca, A.L.; Ficai, D.; Ficai, A. Graphene-Related Nanomaterials for Biomedical Applications. Nanomaterials 2023, 13, 1092. [Google Scholar] [CrossRef] [PubMed]
  23. Halim, A.; Qu, K.Y.; Zhang, X.F.; Huang, N.P. Recent Advances in the Application of Two-Dimensional Nanomaterials for Neural Tissue Engineering and Regeneration. ACS Biomater. Sci. Eng. 2021, 7, 3503–3529. [Google Scholar] [CrossRef] [PubMed]
  24. Zamproni, L.N.; Mundim, M.T.V.V.; Porcionatto, M.A. Neurorepair and Regeneration of the Brain: A Decade of Bioscaffolds and Engineered Microtissue. Front. Cell Dev. Biol. 2021, 9, 649891. [Google Scholar] [CrossRef]
  25. Rantataro, S.; Parkkinen, I.; Pande, I.; Domanskyi, A.; Airavaara, M.; Peltola, E.; Laurila, T. Nanoscale geometry determines mechanical biocompatibility of vertically aligned nanofibers. Acta Biomater. 2022, 146, 235–247. [Google Scholar] [CrossRef]
  26. Khan, F.; Tanaka, M. Designing Smart Biomaterials for Tissue Engineering. Int. J. Mol. Sci. 2017, 19, 17. [Google Scholar] [CrossRef] [Green Version]
  27. Salatino, J.W.; Ludwig, K.A.; Kozai, T.D.Y.; Purcell, E.K. Glial responses to implanted electrodes in the brain. Nat. Biomed. Eng. 2017, 1, 862–877. [Google Scholar] [CrossRef]
  28. Biran, R.; Martin, D.C.; Tresco, P.A. Neuronal cell loss accompanies the brain tissue response to chronically implanted silicon microelectrode arrays. Exp. Neurol. 2005, 195, 115–126. [Google Scholar] [CrossRef]
  29. McConnell, G.C.; Rees, H.D.; Levey, A.I.; Gutekunst, C.A.; Gross, R.E.; Bellamkonda, R.V. Implanted neural electrodes cause chronic, local inflammation that is correlated with local neurodegeneration. J. Neural. Eng. 2009, 6, 056003. [Google Scholar] [CrossRef]
  30. Kozai, T.D.; Gugel, Z.; Li, X.; Gilgunn, P.J.; Khilwani, R.; Ozdoganlar, O.B.; Fedder, G.K.; Weber, D.J.; Cui, X.T. Chronic tissue response to carboxymethyl cellulose based dissolvable insertion needle for ultra-small neural probes. Biomaterials 2014, 35, 9255–9268. [Google Scholar] [CrossRef]
  31. Lee, W.H.; Cha, G.D.; Kim, D.H. Flexible and biodegradable electronic implants for diagnosis and treatment of brain diseases. Curr. Opin. Biotechnol. 2021, 72, 13–21. [Google Scholar] [CrossRef]
  32. Kaurav, H.; Kapoor, D.N. Implantable systems for drug delivery to the brain. Ther. Deliv. 2017, 8, 1097–1107. [Google Scholar] [CrossRef]
  33. Caliari, S.R.; Burdick, J.A. A practical guide to hydrogels for cell culture. Nat. Methods 2016, 13, 405–414. [Google Scholar] [CrossRef] [Green Version]
  34. Xia, T.; Liu, W.; Yang, L. A review of gradient stiffness hydrogels used in tissue engineering and regenerative medicine. J. Biomed. Mater. Res. A 2017, 105, 1799–1812. [Google Scholar] [CrossRef]
  35. Tusan, C.G.; Man, Y.H.; Zarkoob, H.; Johnston, D.A.; Andriotis, O.G.; Thurner, P.J.; Yang, S.; Sander, E.A.; Gentleman, E.; Sengers, B.G.; et al. Collective Cell Behavior in Mechanosensing of Substrate Thickness. Biophys. J. 2018, 114, 2743–2755. [Google Scholar] [CrossRef] [Green Version]
  36. Robinson, M.; Valente, K.P.; Willerth, S.M. A Novel Toolkit for Characterizing the Mechanical and Electrical Properties of Engineered Neural Tissues. Biosensors 2019, 9, 51. [Google Scholar] [CrossRef] [Green Version]
  37. Aregueta-Robles, U.A.; Martens, P.J.; Poole-Warren, L.A.; Green, R.A. Tissue engineered hydrogels supporting 3D neural networks. Acta Biomater. 2019, 95, 269–284. [Google Scholar] [CrossRef]
  38. Rosso, G.; Wehner, D.; Schweitzer, C.; Möllmert, S.; Sock, E.; Guck, J.; Shahin, V. Matrix stiffness mechanosensing modulates the expression and distribution of transcription factors in Schwann cells. Bioeng. Transl. Med. 2021, 7, e10257. [Google Scholar] [CrossRef]
  39. Zhu, J.; Marchant, R.E. Design properties of hydrogel tissue-engineering scaffolds. Expert Rev. Med. Devices 2011, 8, 607–626. [Google Scholar] [CrossRef]
  40. Yang, Y.; Wang, K.; Gu, X.; Leong, K.W. Biophysical Regulation of Cell Behavior-Cross Talk between Substrate Stiffness and Nanotopography. Engineering 2017, 3, 36–54. [Google Scholar] [CrossRef]
  41. Marinval, N.; Chew, S.Y. Mechanotransduction assays for neural regeneration strategies: A focus on glial cells. APL Bioeng. 2021, 5, 021505. [Google Scholar] [CrossRef] [PubMed]
  42. Georges, P.C.; Miller, W.J.; Meaney, D.F.; Sawyer, E.S.; Janmey, P.A. Matrices with compliance comparable to that of brain tissue select neuronal over glial growth in mixed cortical cultures. Biophys. J. 2006, 90, 3012–3018. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Song, L.; Wang, K.; Li, Y.; Yang, Y. Nanotopography promoted neuronal differentiation of human induced pluripotent stem cells. Colloids Surf. B Biointerfaces 2016, 48, 49–58. [Google Scholar] [CrossRef]
  44. Seo, J.; Kim, J.; Joo, S.; Choi, J.Y.; Kang, K.; Cho, W.K.; Choi, I.S. Nanotopography-Promoted Formation of Axon Collateral Branches of Hippocampal Neurons. Small 2018, 20, e1801763. [Google Scholar] [CrossRef] [PubMed]
  45. Fischer, R.S.; Lam, P.Y.; Huttenlocher, A.; Waterman, C.M. Filopodia and focal adhesions: An integrated system driving branching morphogenesis in neuronal pathfinding and angiogenesis. Dev. Biol. 2019, 451, 86–95. [Google Scholar] [CrossRef] [PubMed]
  46. Leclech, C.; Barakat, A.I. Is there a universal mechanism of cell alignment in response to substrate topography? Cytoskeleton 2021, 78, 284–292. [Google Scholar] [CrossRef]
  47. Park, S.; Kim, D.; Park, S.; Kim, S.; Lee, D.; Kim, W.; Kim, J. Nanopatterned Scaffolds for Neural Tissue Engineering and Regenerative Medicine. Adv. Exp. Med. Biol. 2018, 1078, 421–443. [Google Scholar] [CrossRef]
  48. Schnell, E.; Klinkhammer, K.; Balzer, S.; Brook, G.; Klee, D.; Dalton, P.; Mey, J. Guidance of glial cell migration and axonal growth on electrospun nanofibers of poly-epsilon-caprolactone and a collagen/poly-epsilon-caprolactone blend. Biomaterials 2007, 28, 3012–3025. [Google Scholar] [CrossRef]
  49. Jang, M.J.; Namgung, S.; Hong, S.; Nam, Y. Directional neurite growth using carbon nanotube patterned substrates as a biomimetic cue. Nanotechnology 2010, 21, 235102. [Google Scholar] [CrossRef]
  50. Ferrari, A.; Cecchini, M.; Dhawan, A.; Micera, S.; Tonazzini, I.; Stabile, R.; Pisignano, D.; Beltram, F. Nanotopographic control of neuronal polarity. Nano Lett. 2011, 11, 505–511. [Google Scholar] [CrossRef]
  51. Fan, L.; Feng, C.; Zhao, W.; Qian, L.; Wang, Y.; Li, Y. Directional neurite outgrowth on superaligned carbon nanotube yarn patterned substrate. Nano Lett. 2012, 12, 3668–3673. [Google Scholar] [CrossRef]
  52. Krishna, L.; Dhamodaran, K.; Jayadev, C.; Chatterjee, K.; Shetty, R.; Khora, S.S.; Das, D. Nanostructured scaffold as a determinant of stem cell fate. Stem Cell Res. Ther. 2016, 7, 188. [Google Scholar] [CrossRef] [Green Version]
  53. Lee, S.J.; Zhu, W.; Nowicki, M.; Lee, G.; Heo, D.N.; Kim, J.; Zuo, Y.Y.; Zhang, L.G. 3D printing nano conductive multi-walled carbon nanotube scaffolds for nerve regeneration. J. Neural. Eng. 2018, 15, 016018. [Google Scholar] [CrossRef]
  54. Wang, L.; Wu, Y.; Hu, T.; Ma, P.X.; Guo, B. Aligned conductive core-shell biomimetic scaffolds based on nanofiber yarns/hydrogel for enhanced 3D neurite outgrowth alignment and elongation. Acta Biomater. 2019, 96, 175–187. [Google Scholar] [CrossRef]
  55. Moslehi, S.; Rowland, C.; Smith, J.H.; Griffiths, W.; Watterson, W.J.; Niell, C.M.; Alemán, B.J.; Perez, M.T.; Taylor, R.P. Comparison of fractal and grid electrodes for studying the effects of spatial confinement on dissociated retinal neuronal and glial behavior. Sci. Rep. 2022, 12, 17513. [Google Scholar] [CrossRef]
  56. Haq, F.; Anandan, V.; Keith, C.; Zhang, G. Neurite development in PC12 cells cultured on nanopillars and nanopores with sizes comparable with filopodia. Int. J. Nanomed. 2007, 2, 107–115. [Google Scholar] [CrossRef]
  57. Hoffman-Kim, D.; Mitchel, J.A.; Bellamkonda, R.V. Topography, cell response, and nerve regeneration. Annu. Rev. Biomed. Eng. 2010, 12, 203–231. [Google Scholar] [CrossRef] [Green Version]
  58. Leclech, C.; Villard, C. Cellular and Subcellular Contact Guidance on Microfabricated Substrates. Front. Bioeng. Biotechnol. 2020, 8, 551505. [Google Scholar] [CrossRef]
  59. Villard, C. Spatial confinement: A spur for axonal growth. Semin. Cell Dev. Biol. 2023, 140, 54–62. [Google Scholar] [CrossRef]
  60. Onesto, V.; Cancedda, L.; Coluccio, M.L.; Nanni, M.; Pesce, M.; Malara, N.; Cesarelli, M.; Di Fabrizio, E.; Amato, F.; Gentile, F. Nano-topography Enhances Communication in Neural Cells Networks. Sci. Rep. 2017, 7, 9841. [Google Scholar] [CrossRef] [Green Version]
  61. Amores de Sousa, M.C.; Rodrigues, C.A.V.; Ferreira, I.A.F.; Diogo, M.M.; Linhardt, R.J.; Cabral, J.M.S.; Ferreira, F.C. Functionalization of Electrospun Nanofibers and Fiber Alignment Enhance Neural Stem Cell Proliferation and Neuronal Differentiation. Front. Bioeng. Biotechnol. 2020, 8, 580135. [Google Scholar] [CrossRef] [PubMed]
  62. Shan, D.; Ma, C.; Yang, J. Enabling biodegradable functional biomaterials for the management of neurological disorders. Adv. Drug Deliv. Rev. 2019, 148, 219–238. [Google Scholar] [CrossRef] [PubMed]
  63. Jorfi, M.; Skousen, J.L.; Weder, C.; Capadona, J.R. Progress towards biocompatible intracortical microelectrodes for neural interfacing applications. J. Neural. Eng. 2015, 12, 011001. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. D’Amato, A.R.; Puhl, D.L.; Ziemba, A.M.; Johnson, C.D.L.; Doedee, J.; Bao, J.; Gilbert, R.J. Exploring the effects of electrospun fiber surface nanotopography on neurite outgrowth and branching in neuron cultures. PLoS ONE 2019, 14, e0211731. [Google Scholar] [CrossRef] [Green Version]
  65. Miller, R.J.; Chan, C.Y.; Rastogi, A.; Grant, A.M.; White, C.M.; Bette, N.; Schaub, N.J.; Corey, J.M. Combining electrospun nanofibers with cell-encapsulating hydrogel fibers for neural tissue engineering. J. Biomater. Sci. Polym. Ed. 2018, 29, 1625–1642. [Google Scholar] [CrossRef]
  66. Mai, P.; Hampl, J.; Baca, M.; Brauer, D.; Singh, S.; Weise, F.; Borowiec, J.; Schmidt, A.; Küstner, J.M.; Klett, M.; et al. MatriGrid® Based Biological Morphologies: Tools for 3D Cell Culturing. Bioengineering 2022, 9, 220. [Google Scholar] [CrossRef]
  67. Shi, M.; Xu, Q.; Ding, L.; Xia, Y.; Zhang, C.; Lai, H.; Liu, C.; Deng, D.Y.B. Cell Infiltrative Inner Connected Porous Hydrogel Improves Neural Stem Cell Migration and Differentiation for Functional Repair of Spinal Cord Injury. ACS Biomater. Sci. Eng. 2022, 8, 5307–5318. [Google Scholar] [CrossRef]
  68. Li, H.; Wijekoon, A.; Leipzig, N.D. 3D differentiation of neural stem cells in macroporous photopolymerizable hydrogel scaffolds. PLoS ONE 2012, 7, e48824. [Google Scholar] [CrossRef] [Green Version]
  69. Potjewyd, G.; Moxon, S.; Wang, T.; Domingos, M.; Hooper, N.M. Tissue Engineering 3D Neurovascular Units: A Biomaterials and Bioprinting Perspective. Trends Biotechnol. 2018, 36, 457–472. [Google Scholar] [CrossRef]
  70. Moztarzadeh, F.; Sadeghi, A. Design and manufacture of neural tissue engineering scaffolds using hyaluronic acid and polycaprolactone nanofibers with controlled porosity. Mater. Sci. Eng. C Mater. Biol. Appl. 2016, 69, 380–387. [Google Scholar] [CrossRef]
  71. O’Brien, F.J.; Harley, B.A.; Yannas, I.V.; Gibson, L.J. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials 2005, 26, 433–441. [Google Scholar] [CrossRef]
  72. Nam, J.; Huang, Y.; Agarwal, S.; Lannutti, J. Improved cellular infiltration in electrospun fiber via engineered porosity. Tissue Eng. 2007, 13, 2249–2257. [Google Scholar] [CrossRef] [Green Version]
  73. Bružauskaitė, I.; Bironaitė, D.; Bagdonas, E.; Bernotienė, E. Scaffolds and cells for tissue regeneration: Different scaffold pore sizes-different cell effects. Cytotechnology 2016, 68, 355–369. [Google Scholar] [CrossRef] [Green Version]
  74. Yan, M.; Wang, L.; Wu, Y.; Wang, L.; Lu, Y. Three-dimensional highly porous hydrogel scaffold for neural circuit dissection and modulation. Acta Biomater. 2023, 157, 252–262. [Google Scholar] [CrossRef]
  75. Joshi, J.; Homburg, S.V.; Ehrmann, A. Atomic Force Microscopy (AFM) on Biopolymers and Hydrogels for Biotechnological Applications-Possibilities and Limits. Polymers 2022, 14, 1267. [Google Scholar] [CrossRef]
  76. Willerth, S.M.; Sakiyama-Elbert, S.E. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv. Drug Deliv. Rev. 2007, 59, 325–338. [Google Scholar] [CrossRef] [Green Version]
  77. de Sousa Victor, R.; Marcelo da Cunha Santos, A.; Viana de Sousa, B.; de Araújo Neves, G.; Navarro de Lima Santana, L.; Rodrigues Menezes, R. A Review on Chitosan’s Uses as Biomaterial: Tissue Engineering, Drug Delivery Systems and Cancer Treatment. Materials 2020, 13, 4995. [Google Scholar] [CrossRef]
  78. El-Husseiny, H.M.; Mady, E.A.; Hamabe, L.; Abugomaa, A.; Shimada, K.; Yoshida, T.; Tanaka, T.; Yokoi, A.; Elbadawy, M.; Tanaka, R. Smart/stimuli-responsive hydrogels: Cutting-edge platforms for tissue engineering and other biomedical applications. Mater. Today Bio 2021, 13, 100186. [Google Scholar] [CrossRef]
  79. Tarus, D.; Hamard, L.; Caraguel, F.; Wion, D.; Szarpak-Jankowska, A.; van der Sanden, B.; Auzély-Velty, R. Design of Hyaluronic Acid Hydrogels to Promote Neurite Outgrowth in Three Dimensions. ACS Appl. Mater. Interfaces 2016, 8, 25051–25059. [Google Scholar] [CrossRef]
  80. Luo, Y.; Shoichet, M.S. A photolabile hydrogel for guided three-dimensional cell growth and migration. Nat. Mater. 2004, 3, 249–253. [Google Scholar] [CrossRef]
  81. Li, W.; Guo, Y.; Wang, H.; Shi, D.; Liang, C.; Ye, Z.; Qing, F.; Gong, J. Electrospun nanofibers immobilized with collagen for neural stem cells culture. J. Mater. Sci. Mater. Med. 2008, 19, 847–854. [Google Scholar] [CrossRef] [PubMed]
  82. Cheng, T.Y.; Chen, M.H.; Chang, W.H.; Huang, M.Y.; Wang, T.W. Neural stem cells encapsulated in a functionalized self-assembling peptide hydrogel for brain tissue engineering. Biomaterials 2013, 34, 2005–2016. [Google Scholar] [CrossRef] [PubMed]
  83. Balion, Z.; Cėpla, V.; Svirskiene, N.; Svirskis, G.; Druceikaitė, K.; Inokaitis, H.; Rusteikaitė, J.; Masilionis, I.; Stankevičienė, G.; Jelinskas, T.; et al. Cerebellar Cells Self-Assemble into Functional Organoids on Synthetic, Chemically Crosslinked ECM-Mimicking Peptide Hydrogels. Biomolecules 2020, 10, 754. [Google Scholar] [CrossRef]
  84. Long, Y.; Yan, L.; Dai, H.; Yang, D.; Wu, X.; Dong, X.; Liu, K.; Wei, W.; Chen, Y. Enhanced proliferation and differentiation of neural stem cells by peptide-containing temperature-sensitive hydrogel scaffold. Mater. Sci. Eng. C Mater. Biol. Appl. 2020, 116, 111258. [Google Scholar] [CrossRef] [PubMed]
  85. Das, S.; Kumar, R.; Jha, N.N.; Maji, S.K. Controlled Exposure of Bioactive Growth Factor in 3D Amyloid Hydrogel for Stem Cells Differentiation. Adv. Healthc. Mater. 2017, 6, 1700368. [Google Scholar] [CrossRef]
  86. Hatakeyama, M.; Ninomiya, I.; Kanazawa, M. Angiogenesis and neuronal remodeling after ischemic stroke. Neural Regen. Res. 2020, 15, 16–19. [Google Scholar] [CrossRef]
  87. Kfoury, G.; El Habbaki, V.; Malaeb, W.; Weaver, S.; Momotenko, D.; Mhanna, R. Alginate Sulfate Substrates Control Growth Factor Binding and Growth of Primary Neurons: Toward Engineered 3D Neural Networks. Adv. Biosyst. 2020, 4, e2000047. [Google Scholar] [CrossRef]
  88. Lu, J.; Guan, F.; Cui, F.; Sun, X.; Zhao, L.; Wang, Y.; Wang, X. Enhanced angiogenesis by the hyaluronic acid hydrogels immobilized with a VEGF mimetic peptide in a traumatic brain injury model in rats. Regen. Biomater. 2019, 6, 325–334. [Google Scholar] [CrossRef] [Green Version]
  89. McCormick, A.M.; Jarmusik, N.A.; Leipzig, N.D. Co-immobilization of semaphorin3A and nerve growth factor to guide and pattern axons. Acta Biomater. 2015, 28, 33–44. [Google Scholar] [CrossRef] [Green Version]
  90. Delgado-Rivera, R.; Harris, S.L.; Ahmed, I.; Babu, A.N.; Patel, R.P.; Ayres, V.; Flowers, D.; Meiners, S. Increased FGF-2 secretion and ability to support neurite outgrowth by astrocytes cultured on polyamide nanofibrillar matrices. Matrix Biol. 2009, 28, 137–147. [Google Scholar] [CrossRef]
  91. Alberti, K.; Davey, R.E.; Onishi, K.; George, S.; Salchert, K.; Seib, F.P.; Bornhäuser, M.; Pompe, T.; Nagy, A.; Werner, C.; et al. Functional immobilization of signaling proteins enables control of stem cell fate. Nat. Methods 2008, 5, 645–650. [Google Scholar] [CrossRef]
  92. Horne, M.K.; Nisbet, D.R.; Forsythe, J.S.; Parish, C.L. Three-dimensional nanofibrous scaffolds incorporating immobilized BDNF promote proliferation and differentiation of cortical neural stem cells. Stem Cells Dev. 2010, 19, 843–852. [Google Scholar] [CrossRef]
  93. Xia, M.; Zhao, T.; Wang, X.; Li, Y.; Li, Y.; Zheng, T.; Li, J.; Feng, Y.; Wei, Y.; Sun, P. Brain-derived Neurotrophic Factor and Its Applications through Nanosystem Delivery. Iran. J. Pharm. Res. 2021, 20, 137–151. [Google Scholar] [CrossRef]
  94. Klaver, C.L.; Caplan, M.R. Bioactive surface for neural electrodes: Decreasing astrocyte proliferation via transforming growth factor-beta1. J. Biomed. Mater. Res. A 2007, 81, 1011–1016. [Google Scholar] [CrossRef]
  95. Chen, B.K.; Madigan, N.N.; Hakim, J.S.; Dadsetan, M.; McMahon, S.S.; Yaszemski, M.J.; Windebank, A.J. GDNF Schwann cells in hydrogel scaffolds promote regional axon regeneration, remyelination and functional improvement after spinal cord transection in rats. J. Tissue Eng. Regen. Med. 2018, 12, e398–e407. [Google Scholar] [CrossRef] [Green Version]
  96. Alegret, N.; Dominguez-Alfaro, A.; Mecerreyes, D. 3D Scaffolds Based on Conductive Polymers for Biomedical Applications. Biomacromolecules 2019, 20, 73–89. [Google Scholar] [CrossRef]
  97. Bierman-Duquette, R.D.; Safarians, G.; Huang, J.; Rajput, B.; Chen, J.Y.; Wang, Z.Z.; Seidlits, S.K. Engineering Tissues of the Central Nervous System: Interfacing Conductive Biomaterials with Neural Stem/Progenitor Cells. Adv. Healthc. Mater. 2022, 11, e2101577. [Google Scholar] [CrossRef]
  98. Gebeyehu, E.K.; Sui, X.; Adamu, B.F.; Beyene, K.A.; Tadesse, M.G. Cellulosic-Based Conductive Hydrogels for Electro-Active Tissues: A Review Summary. Gels 2022, 8, 140. [Google Scholar] [CrossRef]
  99. Suarez-Cedeno, G.; Suescun, J.; Schiess, M.C. Earlier Intervention with Deep Brain Stimulation for Parkinson’s Disease. Park. Dis. 2017, 2017, 9358153. [Google Scholar] [CrossRef] [Green Version]
  100. Elias, G.J.B.; Namasivayam, A.A.; Lozano, A.M. Deep brain stimulation for stroke: Current uses and future directions. Brain Stimul. 2018, 11, 3–28. [Google Scholar] [CrossRef]
  101. Arya, S.; Filkowski, M.M.; Nanda, P.; Sheth, S.A. Deep brain stimulation for obsessive-compulsive disorder. Bull. Menn. Clin. 2019, 83, 84–96. [Google Scholar] [CrossRef] [PubMed]
  102. Figee, M.; Riva-Posse, P.; Choi, K.S.; Bederson, L.; Mayberg, H.S.; Kopell, B.H. Deep Brain Stimulation for Depression. Neurotherapeutics 2022, 19, 1229–1245. [Google Scholar] [CrossRef] [PubMed]
  103. Gordon, T. Electrical Stimulation to Enhance Axon Regeneration After Peripheral Nerve Injuries in Animal Models and Humans. Neurotherapeutics 2016, 13, 295–310. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Bertucci, C.; Koppes, R.; Dumont, C.; Koppes, A. Neural responses to electrical stimulation in 2D and 3D in vitro environments. Brain Res. Bull. 2019, 152, 265–284. [Google Scholar] [CrossRef] [PubMed]
  105. Doron, G.; Brecht, M. What single-cell stimulation has told us about neural coding. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2015, 370, 20140204. [Google Scholar] [CrossRef] [Green Version]
  106. Edwards, C.A.; Kouzani, A.; Lee, K.H.; Ross, E.K. Neurostimulation Devices for the Treatment of Neurologic Disorders. Mayo Clin. Proc. 2017, 92, 1427–1444. [Google Scholar] [CrossRef] [Green Version]
  107. Huang, A.P.; Lai, D.M.; Hsu, Y.H.; Tsai, H.H.; Su, C.Y.; Hsu, S.H. An anti-inflammatory gelatin hemostatic agent with biodegradable polyurethane nanoparticles for vulnerable brain tissue. Mater. Sci. Eng. C Mater. Biol. Appl. 2021, 121, 111799. [Google Scholar] [CrossRef]
  108. Fabbro, A.; Cellot, G.; Prato, M.; Ballerini, L. Interfacing neurons with carbon nanotubes: (Re)engineering neuronal signaling. Prog. Brain Res. 2011, 194, 241–252. [Google Scholar] [CrossRef]
  109. John, A.A.; Subramanian, A.P.; Vellayappan, M.V.; Balaji, A.; Mohandas, H.; Jaganathan, S.K. Carbon nanotubes and graphene as emerging candidates in neuroregeneration and neurodrug delivery. Int. J. Nanomed. 2015, 10, 4267–4277. [Google Scholar] [CrossRef] [Green Version]
  110. Gibney, S.; Hicks, J.M.; Robinson, A.; Jain, A.; Sanjuan-Alberte, P.; Rawson, F.J. Toward nanobioelectronic medicine: Unlocking new applications using nanotechnology. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2021, 13, e1693. [Google Scholar] [CrossRef]
  111. Cellot, G.; Cilia, E.; Cipollone, S.; Rancic, V.; Sucapane, A.; Giordani, S.; Gambazzi, L.; Markram, H.; Grandolfo, M.; Scaini, D.; et al. Carbon nanotubes might improve neuronal performance by favouring electrical shortcuts. Nat. Nanotechnol. 2009, 4, 126–133. [Google Scholar] [CrossRef]
  112. Bareket-Keren, L.; Hanein, Y. Carbon nanotube-based multi electrode arrays for neuronal interfacing: Progress and prospects. Front. Neural. Circuits 2013, 6, 122. [Google Scholar] [CrossRef] [Green Version]
  113. Cellot, G.; Franceschi Biagioni, A.; Ballerini, L. Nanomedicine and graphene-based materials: Advanced technologies for potential treatments of diseases in the developing nervous system. Pediatr. Res. 2022, 92, 71–79. [Google Scholar] [CrossRef]
  114. Lanone, S.; Andujar, P.; Kermanizadeh, A.; Boczkowski, J. Determinants of carbon nanotube toxicity. Adv. Drug Deliv. Rev. 2013, 65, 2063–2069. [Google Scholar] [CrossRef]
  115. Chetyrkina, M.R.; Fedorov, F.S.; Nasibulin, A.G. In vitro toxicity of carbon nanotubes: A systematic review. RSC Adv. 2022, 12, 16235–16256. [Google Scholar] [CrossRef]
  116. Salih, S.J.; Ghobadi, M.Z. Evaluating the cytotoxicity and pathogenicity of multi-walled carbon nanotube through weighted gene co-expression network analysis: A nanotoxicogenomics study. BMC Genom. Data 2022, 23, 12. [Google Scholar] [CrossRef]
  117. Duke, K.S.; Bonner, J.C. Mechanisms of carbon nanotube-induced pulmonary fibrosis: A physicochemical characteristic perspective. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2018, 10, e1498. [Google Scholar] [CrossRef]
  118. Ema, M.; Gamo, M.; Honda, K. A review of toxicity studies of single-walled carbon nanotubes in laboratory animals. Regul. Toxicol. Pharmacol. 2016, 74, 42–63. [Google Scholar] [CrossRef]
  119. Liang, Y.; Goh, J.C. Polypyrrole-Incorporated Conducting Constructs for Tissue Engineering Applications: A Review. Bioelectricity 2020, 2, 101–119. [Google Scholar] [CrossRef]
  120. Farokhi, M.; Mottaghitalab, F.; Saeb, M.R.; Shojaei, S.; Zarrin, N.K.; Thomas, S.; Ramakrishna, S. Conductive Biomaterials as Substrates for Neural Stem Cells Differentiation towards Neuronal Lineage Cells. Macromol. Biosci. 2021, 21, e2000123. [Google Scholar] [CrossRef]
  121. Humpolíček, P.; Kašpárková, V.; Pacherník, J.; Stejskal, J.; Bober, P.; Capáková, Z.; Radaszkiewicz, K.A.; Junkar, I.; Lehocký, M. The biocompatibility of polyaniline and polypyrrole: A comparative study of their cytotoxicity, embryotoxicity and impurity profile. Mater. Sci. Eng. C Mater. Biol. Appl. 2018, 91, 303–310. [Google Scholar] [CrossRef] [PubMed]
  122. Garrudo, F.F.F.; Mikael, P.E.; Rodrigues, C.A.V.; Udangawa, R.W.; Paradiso, P.; Chapman, C.A.; Hoffman, P.; Colaço, R.; Cabral, J.M.S.; Morgado, J.; et al. Polyaniline-polycaprolactone fibers for neural applications: Electroconductivity enhanced by pseudo-doping. Mater. Sci. Eng. C Mater. Biol. Appl. 2021, 120, 111680. [Google Scholar] [CrossRef] [PubMed]
  123. Pires, F.; Ferreira, Q.; Rodrigues, C.A.; Morgado, J.; Ferreira, F.C. Neural stem cell differentiation by electrical stimulation using a cross-linked PEDOT substrate: Expanding the use of biocompatible conjugated conductive polymers for neural tissue engineering. Biochim. Biophys. Acta 2015, 1850, 1158–1168. [Google Scholar] [CrossRef] [PubMed]
  124. Zhang, Z.; Tian, G.; Duan, X.; Chen, H.L.; Kim Richie, D.H. Nanostructured PEDOT Coatings for Electrode-Neuron Integration. ACS Appl. Bio Mater. 2021, 4, 5556–5565. [Google Scholar] [CrossRef]
  125. Widge, A.S.; Jeffries-El, M.; Cui, X.; Lagenaur, C.F.; Matsuoka, Y. Self-assembled monolayers of polythiophene conductive polymers improve biocompatibility and electrical impedance of neural electrodes. Biosens. Bioelectron. 2007, 2022, 1723–1732. [Google Scholar] [CrossRef]
  126. Yu, Z.H.; Chen, W.J.; Liu, X.; Xia, Q.Y.; Yang, Y.N.; Dong, M.; Liu, J.H.; Guan, H.J.; Sun, C.; Feng, F.D.; et al. Folate-Modified Photoelectric Responsive Polymer Microarray as Bionic Artificial Retina to Restore Visual Function. ACS Appl. Mater. Interfaces 2020, 12, 28759–28767. [Google Scholar] [CrossRef]
  127. Granato, A.E.C.; Ribeiro, A.C.; Marciano, F.R.; Rodrigues, B.V.M.; Lobo, A.O.; Porcionatto, M. Polypyrrole increases branching and neurite extension by Neuro2A cells on PBAT ultrathin fibers. Nanomedicine 2018, 14, 1753–1763. [Google Scholar] [CrossRef]
  128. Cui, C.; Faraji, N.; Lauto, A.; Travaglini, L.; Tonkin, J.; Mahns, D.; Humphrey, E.; Terracciano, C.; Gooding, J.J.; Seidel, J.; et al. A flexible polyaniline-based bioelectronic patch. Biomater. Sci. 2018, 6, 493–500. [Google Scholar] [CrossRef]
  129. Richardson-Burns, S.M.; Hendricks, J.L.; Foster, B.; Povlich, L.K.; Kim, D.H.; Martin, D.C. Polymerization of the conducting polymer poly(3,4-ethylenedioxythiophene) (PEDOT) around living neural cells. Biomaterials 2007, 28, 1539–1552. [Google Scholar] [CrossRef] [Green Version]
  130. Asplund, M.; Thaning, E.; Lundberg, J.; Sandberg-Nordqvist, A.C.; Kostyszyn, B.; Inganäs, O.; von Holst, H. Toxicity evaluation of PEDOT/biomolecular composites intended for neural communication electrodes. Biomed. Mater. 2009, 4, 045009. [Google Scholar] [CrossRef]
  131. Kolaya, E.; Firestein, B.L. Deep brain stimulation: Challenges at the tissue-electrode interface and current solutions. Biotechnol. Prog. 2021, 37, e3179. [Google Scholar] [CrossRef]
  132. Limongi, T.; Rocchi, A.; Cesca, F.; Tan, H.; Miele, E.; Giugni, A.; Orlando, M.; Perrone Donnorso, M.; Perozziello, G.; Benfenati, F.; et al. Delivery of Brain-Derived Neurotrophic Factor by 3D Biocompatible Polymeric Scaffolds for Neural Tissue Engineering and Neuronal Regeneration. Mol. Neurobiol. 2018, 55, 8788–8798. [Google Scholar] [CrossRef]
  133. Villanueva-Flores, F.; Castro-Lugo, A.; Ramírez, O.T.; Palomares, L.A. Understanding cellular interactions with nanomaterials: Towards a rational design of medical nanodevices. Nanotechnology 2020, 31, 132002. [Google Scholar] [CrossRef]
  134. Shabani, L.; Abbasi, M.; Azarnew, Z.; Amani, A.M.; Vaez, A. Neuro-nanotechnology: Diagnostic and therapeutic nano-based strategies in applied neuroscience. Biomed. Eng. Online 2023, 22, 1. [Google Scholar] [CrossRef]
  135. Knowlton, S.; Anand, S.; Shah, T.; Tasoglu, S. Bioprinting for Neural Tissue Engineering. Trends Neurosci. 2018, 41, 31–46. [Google Scholar] [CrossRef]
  136. Matai, I.; Kaur, G.; Seyedsalehi, A.; McClinton, A.; Laurencin, C.T. Progress in 3D bioprinting technology for tissue/organ regenerative engineering. Biomaterials 2020, 226, 119536. [Google Scholar] [CrossRef]
  137. Cadena, M.; Ning, L.; King, A.; Hwang, B.; Jin, L.; Serpooshan, V.; Sloan, S.A. 3D Bioprinting of Neural Tissues. Adv. Healthc. Mater. 2021, 10, e2001600. [Google Scholar] [CrossRef]
  138. Pawar, K.; Prang, P.; Müller, R.; Caioni, M.; Bogdahn, U.; Kunz, W.; Weidner, N. Intrinsic and extrinsic determinants of central nervous system axon outgrowth into alginate-based anisotropic hydrogels. Acta Biomater. 2015, 27, 131–139. [Google Scholar] [CrossRef]
  139. Wang, Y.; Cooke, M.J.; Morshead, C.M.; Shoichet, M.S. Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury. Biomaterials 2012, 33, 2681–2692. [Google Scholar] [CrossRef]
  140. Mo, L.; Yang, Z.; Zhang, A.; Li, X. The repair of the injured adult rat hippocampus with NT-3-chitosan carriers. Biomaterials 2010, 31, 2184–2192. [Google Scholar] [CrossRef]
  141. Azadi, A.; Hamidi, M.; Rouini, M.R. Methotrexate-loaded chitosan nanogels as ‘Trojan Horses’ for drug delivery to brain: Preparation and in vitro/in vivo characterization. Int. J. Biol. Macromol. 2013, 62, 523–530. [Google Scholar] [CrossRef] [PubMed]
  142. Huang, C.; Zhao, L.; Gu, J.; Nie, D.; Chen, Y.; Zuo, H.; Huan, W.; Shi, J.; Chen, J.; Shi, W. The migration and differentiation of hUC-MSCs(CXCR4/GFP) encapsulated in BDNF/chitosan scaffolds for brain tissue engineering. Biomed. Mater. 2016, 11, 035004. [Google Scholar] [CrossRef] [PubMed]
  143. Gil, V.; del Río, J.A. Analysis of axonal growth and cell migration in 3D hydrogel cultures of embryonic mouse CNS tissue. Nat. Protoc. 2012, 7, 268–280. [Google Scholar] [CrossRef] [PubMed]
  144. Duan, H.; Li, X.; Wang, C.; Hao, P.; Song, W.; Li, M.; Zhao, W.; Gao, Y.; Yang, Z. Functional hyaluronate collagen scaffolds induce NSCs differentiation into functional neurons in repairing the traumatic brain injury. Acta Biomater. 2016, 45, 182–195. [Google Scholar] [CrossRef] [PubMed]
  145. Wang, T.W.; Chang, K.C.; Chen, L.H.; Liao, S.Y.; Yeh, C.W.; Chuang, Y.J. Effects of an injectable functionalized self-assembling nanopeptide hydrogel on angiogenesis and neurogenesis for regeneration of the central nervous system. Nanoscale 2017, 9, 16281–16292. [Google Scholar] [CrossRef]
  146. Lim, T.C.; Toh, W.S.; Wang, L.S.; Kurisawa, M.; Spector, M. The effect of injectable gelatin-hydroxyphenylpropionic acid hydrogel matrices on the proliferation, migration, differentiation and oxidative stress resistance of adult neural stem cells. Biomaterials 2012, 33, 3446–3455. [Google Scholar] [CrossRef]
  147. Sarnowska, A.; Jablonska, A.; Jurga, M.; Dainiak, M.; Strojek, L.; Drela, K.; Wright, K.; Tripathi, A.; Kumar, A.; Jungvid, H.; et al. Encapsulation of mesenchymal stem cells by bioscaffolds protects cell survival and attenuates neuroinflammatory reaction in injured brain tissue after transplantation. Cell Transpl. 2013, 22 (Suppl. 1), S67–S82. [Google Scholar] [CrossRef]
  148. Kumosa, L.S.; Zetterberg, V.; Schouenborg, J. Gelatin promotes rapid restoration of the blood brain barrier after acute brain injury. Acta Biomater. 2018, 65, 137–149. [Google Scholar] [CrossRef]
  149. Moshayedi, P.; Nih, L.R.; Llorente, I.L.; Berg, A.R.; Cinkornpumin, J.; Lowry, W.E.; Segura, T.; Carmichael, S.T. Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain. Biomaterials 2016, 105, 145–155. [Google Scholar] [CrossRef] [Green Version]
  150. Wang, L.; Zhang, D.; Ren, Y.; Guo, S.; Li, J.; Ma, S.; Yao, M.; Guan, F. Injectable hyaluronic acid hydrogel loaded with BMSC and NGF for traumatic brain injury treatment. Mater. Today Bio 2021, 13, 100201. [Google Scholar] [CrossRef]
  151. Nisbet, D.R.; Rodda, A.E.; Horne, M.K.; Forsythe, J.S.; Finkelstein, D.I. Implantation of functionalized thermally gelling xyloglucan hydrogel within the brain: Associated neurite infiltration and inflammatory response. Tissue Eng. Part A 2010, 16, 2833–2842. [Google Scholar] [CrossRef]
  152. Villanueva-Flores, F.; Miranda-Hernández, M.; Flores-Flores, J.O.; Porras-Sanjuanico, A.; Hu, H.; Pérez-Martínez, L.; Ramírez, O.T.; Palomares, L.A. Poly(vinyl alcohol co-vinyl acetate) as a novel scaffold for mammalian cell culture and controlled drug release. J. Mater. Sci. 2019, 54, 7867–7882. [Google Scholar] [CrossRef]
  153. Fon, D.; Zhou, K.; Ercole, F.; Fehr, F.; Marchesan, S.; Minter, M.R.; Crack, P.J.; Finkelstein, D.I.; Forsythe, J.S. Nanofibrous scaffolds releasing a small molecule BDNF-mimetic for the re-direction of endogenous neuroblast migration in the brain. Biomaterials 2014, 35, 2692–2712. [Google Scholar] [CrossRef]
  154. Bjugstad, K.B.; Lampe, K.; Kern, D.S.; Mahoney, M. Biocompatibility of poly(ethylene glycol)-based hydrogels in the brain: An analysis of the glial response across space and time. J. Biomed. Mater. Res. A 2010, 95, 79–91. [Google Scholar] [CrossRef]
  155. Lampe, K.J.; Kern, D.S.; Mahoney, M.J.; Bjugstad, K.B. The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG-based hydrogel: Protein distribution and the glial response. J. Biomed. Mater. Res A 2011, 96, 595–607. [Google Scholar] [CrossRef]
  156. Jhaveri, S.J.; Hynd, M.R.; Dowell-Mesfin, N.; Turner, J.N.; Shain, W.; Ober, C.K. Release of nerve growth factor from HEMA hydrogel-coated substrates and its effect on the differentiation of neural cells. Biomacromolecules 2009, 10, 174–183. [Google Scholar] [CrossRef]
  157. Plant, G.W.; Woerly, S.; Harvey, A.R. Hydrogels containing peptide or aminosugar sequences implanted into the rat brain: Influence on cellular migration and axonal growth. Exp. Neurol. 1997, 143, 287–299. [Google Scholar] [CrossRef]
  158. Álvarez, Z.; Castaño, O.; Castells, A.A.; Mateos-Timoneda, M.A.; Planell, J.A.; Engel, E.; Alcántara, S. Neurogenesis and vascularization of the damaged brain using a lactate-releasing biomimetic scaffold. Biomaterials 2014, 35, 4769–4781. [Google Scholar] [CrossRef]
  159. Carlberg, B.; Axell, M.Z.; Nannmark, U.; Liu, J.; Kuhn, H.G. Electrospun polyurethane scaffolds for proliferation and neuronal differentiation of human embryonic stem cells. Biomed. Mater. 2009, 4, 045004. [Google Scholar] [CrossRef]
  160. Hsieh, F.Y.; Lin, H.H.; Hsu, S.H. 3D bioprinting of neural stem cell-laden thermoresponsive biodegradable polyurethane hydrogel and potential in central nervous system repair. Biomaterials 2015, 71, 48–57. [Google Scholar] [CrossRef]
  161. Aligholi, H.; Rezayat, S.M.; Azari, H.; Ejtemaei Mehr, S.; Akbari, M.; Modarres Mousavi, S.M.; Attari, F.; Alipour, F.; Hassanzadeh, G.; Gorji, A. Preparing neural stem/progenitor cells in PuraMatrix hydrogel for transplantation after brain injury in rats: A comparative methodological study. Brain Res. 2016, 1642, 197–208. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  162. Wadhwa, R.; Lagenaur, C.F.; Cui, X.T. Electrochemically controlled release of dexamethasone from conducting polymer polypyrrole coated electrode. J. Control. Release 2006, 110, 531–541. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  163. Zhang, Q.; Esrafilzadeh, D.; Crook, J.M.; Kapsa, R.; Stewart, E.M.; Tomaskovic-Crook, E.; Wallace, G.G.; Huang, X.F. Electrical Stimulation Using Conductive Polymer Polypyrrole Counters Reduced Neurite Outgrowth of Primary Prefrontal Cortical Neurons from NRG1-KO and DISC1-LI Mice. Sci. Rep. 2017, 7, 42525. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  164. Zarrintaj, P.; Ahmadi, Z.; Vahabi, H.; Ducos, F.; Reza Saeb, M.; Mozafari, M. Polyaniline in retrospect and prospect. Mater. Today Proc. 2018, 5, 15852–15860. [Google Scholar] [CrossRef]
  165. Mandal, H.S.; Knaack, G.L.; Charkhkar, H.; McHail, D.G.; Kastee, J.S.; Dumas, T.C.; Peixoto, N.; Rubinson, J.F.; Pancrazio, J.J. Improving the performance of poly(3,4-ethylenedioxythiophene) for brain-machine interface applications. Acta Biomater. 2014, 10, 2446–2454. [Google Scholar] [CrossRef]
  166. Tang, W.; Fang, F.; Liu, K.; Huang, Z.; Li, H.; Yin, Y.; Wang, J.; Wang, G.; Wei, L.; Ou, Y.; et al. Aligned Biofunctional Electrospun PLGA-LysoGM1 Scaffold for Traumatic Brain Injury Repair. ACS Biomater. Sci. Eng. 2020, 6, 2209–2218. [Google Scholar] [CrossRef]
  167. Smith, L.A.; Liu, X.; Ma, P.X. Tissue Engineering with Nano-Fibrous Scaffolds. Soft Matter. 2008, 4, 2144–2149. [Google Scholar] [CrossRef] [Green Version]
  168. Diban, N.; Ramos-Vivas, J.; Remuzgo-Martinez, S.; Ortiz, I.; Urtiaga, A. Poly(ε-caprolactone) films with favourable properties for neural cell growth. Curr. Top. Med. Chem. 2014, 14, 2743–2749. [Google Scholar] [CrossRef]
  169. Yang, K.; Lee, J.; Lee, J.S.; Kim, D.; Chang, G.E.; Seo, J.; Cheong, E.; Lee, T.; Cho, S.W. Graphene Oxide Hierarchical Patterns for the Derivation of Electrophysiologically Functional Neuron-like Cells from Human Neural Stem Cells. ACS Appl. Mater. Interfaces 2016, 8, 17763–17774. [Google Scholar] [CrossRef]
  170. Tong, A.; Voronov, R. A Minireview of Microfluidic Scaffold Materials in Tissue Engineering. Front. Mol. Biosci. 2022, 8, 783268. [Google Scholar] [CrossRef]
  171. Skop, N.B.; Calderon, F.; Cho, C.H.; Gandhi, C.D.; Levison, S.W. Optimizing a multifunctional microsphere scaffold to improve neural precursor cell transplantation for traumatic brain injury repair. J. Tissue Eng. Regen. Med. 2016, 10, E419–E432. [Google Scholar] [CrossRef]
  172. Büyüköz, M.; Erdal, E.; Alsoy Altinkaya, S. Nanofibrous gelatine scaffolds integrated with nerve growth factor-loaded alginate microspheres for brain tissue engineering. J. Tissue Eng. Regen. Med. 2018, 12, e707–e719. [Google Scholar] [CrossRef]
  173. Sozzi, E.; Kajtez, J.; Bruzelius, A.; Wesseler, M.F.; Nilsson, F.; Birtele, M.; Larsen, N.B.; Ottosson, D.R.; Storm, P.; Parmar, M.; et al. Silk scaffolding drives self-assembly of functional and mature human brain organoids. Front. Cell Dev. Biol. 2022, 10, 1023279. [Google Scholar] [CrossRef]
  174. Yadav, S.; Sharma, A.K.; Kumar, P. Nanoscale Self-Assembly for Therapeutic Delivery. Front. Bioeng. Biotechnol. 2020, 8, 127. [Google Scholar] [CrossRef] [Green Version]
  175. Layrolle, P.; Payoux, P.; Chavanas, S. Message in a Scaffold: Natural Biomaterials for Three-Dimensional (3D) Bioprinting of Human Brain Organoids. Biomolecules 2022, 13, 25. [Google Scholar] [CrossRef]
  176. Hong, D.; Bae, K.; Yoo, S.; Kang, K.; Jang, B.; Kim, J.; Kim, S.; Jeon, S.; Nam, Y.; Kim, Y.G.; et al. Generation of cellular micropatterns on a single-layered graphene film. Macromol. Biosci. 2014, 14, 314–319. [Google Scholar] [CrossRef]
  177. Namba, R.M.; Cole, A.A.; Bjugstad, K.B.; Mahoney, M.J. Development of porous PEG hydrogels that enable efficient, uniform cell-seeding and permit early neural process extension. Acta Biomater. 2009, 5, 1884–1897. [Google Scholar] [CrossRef]
  178. Mooney, D.J.; Baldwin, D.F.; Suh, N.P.; Vacanti, J.P.; Langer, R. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 1996, 17, 1417–1422. [Google Scholar] [CrossRef]
Figure 1. Parameters and strategies for designing scaffolds for brain tissue engineering. In the blue circle, the main parameters to be considered in the design of scaffolds are addressed. The main strategies to cover each parameter are described in the yellow circle. In the green circle, some examples are presented. BNDF: brain-derived neurotrophic factor; VEGF: vascular endothelial growth factor; TFG-β: transforming growth factor-beta; ROS: reactive oxygen species; RGD: arginine-glycine-aspartate.
Figure 1. Parameters and strategies for designing scaffolds for brain tissue engineering. In the blue circle, the main parameters to be considered in the design of scaffolds are addressed. The main strategies to cover each parameter are described in the yellow circle. In the green circle, some examples are presented. BNDF: brain-derived neurotrophic factor; VEGF: vascular endothelial growth factor; TFG-β: transforming growth factor-beta; ROS: reactive oxygen species; RGD: arginine-glycine-aspartate.
Pharmaceutics 15 01750 g001
Figure 2. Simplified scheme of an implanted hydrogel used as a platform to establish novel neuronal connections. The hydrogel is a platform for exogen cell growth that establishes novel neuronal connections with the host cells. The cell patch remains in the repaired tissue zone.
Figure 2. Simplified scheme of an implanted hydrogel used as a platform to establish novel neuronal connections. The hydrogel is a platform for exogen cell growth that establishes novel neuronal connections with the host cells. The cell patch remains in the repaired tissue zone.
Pharmaceutics 15 01750 g002
Figure 3. Mechanical properties of the brain and various other materials for neural tissue engineering. Comparing Young’s moduli, we see a differentiation between images located in letters (a) brain and other soft tissues, and (b) materials applied in neuronal cell culture. The range of Young’s moduli for materials suitable for cultivating neural cells is in image (c). PAAm: polyacrylamide, PEG: poly(ethylene glycol), PDMS: poly(dymethylsiloxane), PS: polyestyrene, PLGA: poly(lactic-co-glycolic acid), PCL: poly ɛ-caprolactone, Si: silicon, Ti: Titanium. Modified from [40].
Figure 3. Mechanical properties of the brain and various other materials for neural tissue engineering. Comparing Young’s moduli, we see a differentiation between images located in letters (a) brain and other soft tissues, and (b) materials applied in neuronal cell culture. The range of Young’s moduli for materials suitable for cultivating neural cells is in image (c). PAAm: polyacrylamide, PEG: poly(ethylene glycol), PDMS: poly(dymethylsiloxane), PS: polyestyrene, PLGA: poly(lactic-co-glycolic acid), PCL: poly ɛ-caprolactone, Si: silicon, Ti: Titanium. Modified from [40].
Pharmaceutics 15 01750 g003
Table 1. Immobilized growth factors in scaffolds for neural tissue engineering.
Table 1. Immobilized growth factors in scaffolds for neural tissue engineering.
Immobilized Growth FactorEffectSubstrateReference
VEGFEnhanced angiogenesis and inhibited formation of glial scars at the injured sitesHA[88]
NGF and FGF-2Improves extension and infiltration of neurites and provides neurite guidance.Chitosan films, Polyamide nanofibers.[89,90]
LIF and SCFMaintenance of pluripotent state up to two weeks.Maleic anhydride copolymer thin films.[91]
BNDFTriggers pluripotent cell differentiation into specific lineages such as neurons or oligodendrocytes, and improvement in synaptic communication. Enhances neural stem cell proliferation.3-D electrospun poly-epsilon-caprolactone nanofibers.[92,93]
TGF-β1Reduced astrocyte proliferation and glial scar.Oxidized dextran with sodium metaperiodate.[94]
GDNFIncreased myelination of regenerating axons.Positively-charged oligo[poly(ethylene glycol)fumarate].[95]
VEGF: Vascular endothelial growth factor, NGF: nerve growth factor, FGF-2: fibroblast growth factor 2, LIF: leukemia inhibitor factor, SCF: stem cell factor, BNDF: brain-derived neurotrophic factor; TFG-β: transforming growth factor-beta, GDNF: glial-cell-derived neurotrophic factor.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Villanueva-Flores, F.; Garcia-Atutxa, I.; Santos, A.; Armendariz-Borunda, J. Toward a New Generation of Bio-Scaffolds for Neural Tissue Engineering: Challenges and Perspectives. Pharmaceutics 2023, 15, 1750. https://doi.org/10.3390/pharmaceutics15061750

AMA Style

Villanueva-Flores F, Garcia-Atutxa I, Santos A, Armendariz-Borunda J. Toward a New Generation of Bio-Scaffolds for Neural Tissue Engineering: Challenges and Perspectives. Pharmaceutics. 2023; 15(6):1750. https://doi.org/10.3390/pharmaceutics15061750

Chicago/Turabian Style

Villanueva-Flores, Francisca, Igor Garcia-Atutxa, Arturo Santos, and Juan Armendariz-Borunda. 2023. "Toward a New Generation of Bio-Scaffolds for Neural Tissue Engineering: Challenges and Perspectives" Pharmaceutics 15, no. 6: 1750. https://doi.org/10.3390/pharmaceutics15061750

APA Style

Villanueva-Flores, F., Garcia-Atutxa, I., Santos, A., & Armendariz-Borunda, J. (2023). Toward a New Generation of Bio-Scaffolds for Neural Tissue Engineering: Challenges and Perspectives. Pharmaceutics, 15(6), 1750. https://doi.org/10.3390/pharmaceutics15061750

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop